IOB - Delayed Quote CHF

Eli Lilly and Company (0Q1G.IL)

540.00

0.00

(0.00%)

At close: July 23 at 9:00:00 PM GMT+1

Lilly to offer all approved doses of Zepbound (tirzepatide) single-dose vials through LillyDirect Self Pay Pharmacy Solutions

Eli Lilly and Company (NYSE: LLY) today announced that the highest approved doses of Zepbound (tirzepatide)—12.5 mg and 15 mg—will soon be available in single-dose vials for $499 per month through LillyDirect's Self Pay Pharmacy Solutions and the Zepbound Self Pay Journey Program.1 Health care providers can begin prescribing the 12.5 mg and 15 mg vials on July 7, and shipments to patients will begin in early August. With the addition of these doses, every strength of Zepbound vial will be availa

PR Newswire 10 hours ago

LLY
Pharma manufacturing 'boom' faces high costs, potential delays

Here are Big Pharma's plans to reshore manufacturing amid cost and policy headwinds.

Yahoo Finance yesterday

JNJ

LLY

SKBSY
Tariffs Create Most Patriotic Earnings Season Yet as US Firms Pander to Trump

(Bloomberg) -- Supply Lines is a daily newsletter that tracks global trade. Sign up here.Most Read from BloombergShuttered NY College Has Alumni Fighting Over Its FutureTrump’s Military Parade Has Washington Bracing for Tanks and WeaponryNYC Renters Brace for Price Hikes After Broker-Fee BanDo World’s Fairs Still Matter?As Part of a $45 Billion Push, ICE Prepares for a Vast Expansion of Detention SpacePresident Donald Trump’s tariff regime may not be having the desired effect of bringing manufac

Bloomberg 3 days ago

LLY

DE

BMY
Abbott Laboratories Stock Sees RS Rating Rise To 82

On Thursday, Abbott Laboratories stock earned a positive adjustment to its Relative Strength (RS) Rating, from 78 to 82. The medical device firm recently announced a collaboration with Tandem Diabetes Care to develop automated insulin delivery systems using a dual glucose-ketone sensor.

Investor's Business Daily 4 days ago

ABT

LLY
Eli Lilly (NYSE:LLY) Collaborates With Juvena To Enhance Muscle Health Through AI Technology

Eli Lilly (NYSE:LLY) announced a significant global licensing and research collaboration with Juvena Therapeutics to explore AI-driven drug candidates for muscle health. This innovative move, alongside other significant developments like the Cialis acquisition in Latin America, underscores the company's commitment to expanding its product portfolio and reaching new markets. Over the past month, Eli Lilly's stock rose by nearly 10%, a performance that aligns with the broader upward trend of...

Simply Wall St. 5 days ago

LLY
Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: VACCINE ADVISORY COMMITTEE: In an opinion article published by The Wall Street Journal, Robert F. Kennedy Jr. stated, “Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agenci

TipRanks 5 days ago

RHHBF

RHHBY

RHHVF
Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to

Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.

Yahoo Finance 5 days ago

HIMS

LLY

NONOF
Eli Lilly telehealth deals to prevent sale of compounded GLP-1s

Eli Lilly (LLY) revealed a new stipulation regarding its business dealings with telehealth companies Ro and LifeMD (LFMD), ensuring that compounded versions of its GLP-1 weight-loss drugs are not being sold on these sites. Yahoo Finance senior health reporter Anjalee Khemlani sheds more light on this and compares other GLP-1 manufacturers' telehealth deals. Also watch Anjalee Khemlani's coverage of US Health Secretary Robert F. Kennedy, Jr.'s decision to remove all 17 members of the Centers for Disease Control and Prevention's (CDC) vaccine advisory panel. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video 6 days ago

NONOF

NVO

LFMD
Weight-Loss Drugs Pose Long-Term Threat To McDonald's: Analyst

McDonald's stock was cut from buy to sell over a potential double-digit loss in sales due to weight-loss drugs.

Investor's Business Daily 6 days ago

MCD

LLY

NONOF
Obesity Newcomer Metsera Enters The Ring With A Punch — And A Big Stock Jump

Metsera stock surged Monday after the drugmaker unveiled "solid" results for a potential monthly shot to stoke weight loss.

Investor's Business Daily 7 days ago

MTSR

NONOF

NVO
Challenges pharma companies face in push into US manufacturing

Yahoo Finance senior health reporter Anjalee Khemlani explains the pharmaceutical industry's push into domestic manufacturing in the US, as a reshoring tactic to tighten up the supply chain. Planning can still take several years to be finalized and face cost barriers amid tariffs. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video 10 days ago

SNY

SNYNF

LLY
The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.

Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.

Investor's Business Daily 10 days ago

NONOF

NVO

AMGN
Salesforce initiated, Dollar Tree upgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: JPMorgan upgraded Dollar Tree (DLTR) to Overweight from Neutral with a price target of $111, up from $72, following the post-earnings selloff. The company’s Q1 same-store sales came in above consensus with balanced ticket and traffic composition, the firm tells investors in a research note. Monness Cre

TipRanks 10 days ago

DLTR

MELI

V
Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Booster Shot

Ireland’s economy grew three times as rapidly as first estimated in the first quarter. That was driven by stockpiling of pharmaceuticals and other goods by U.S. businesses ahead of threatened tariffs.

The Wall Street Journal 11 days ago

LLY

PFE
These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Broadcom Results Ahead

As the stock market extends its rebound, it's important to watch the stocks most loved among equity analysts. Netflix and GE Aerospace are two of the seven best stocks where investors can find magnificent profit growth prospects. Of 54 analysts covering Netflix, 38 have buy or overweight ratings on the video streaming service.

Investor's Business Daily 12 days ago

AXON

ISRG

V
Eli Lilly (NYSE:LLY) Advances Ovarian Cancer Treatment And Transfers Cialis Rights In Latin America

Eli Lilly (NYSE:LLY) recently announced promising Phase 1 data for its folate receptor alpha antibody-drug conjugate, showcasing significant progress in oncology treatments for ovarian cancer. Additionally, the acquisition of Cialis rights in Latin America by Grünenthal highlights a strategic shift in their partnership. Over the past week, Eli Lilly's share price rose by 5%, slightly above the market's 2% increase. While the recent positive news in oncology and the acquisition may have...

Simply Wall St. 13 days ago

LLY
Lilly to participate in Goldman Sachs 46th Annual Global Health Care Conference

Eli Lilly and Company (NYSE:LLY) will participate in the Goldman Sachs 46th Annual Global Health Care Conference on June 10, 2025. Lucas Montarce, Lilly executive vice president and chief financial officer, will take part in a fireside chat at 8 a.m., Eastern time.

PR Newswire 14 days ago

LLY
Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting

Eli Lilly and Company (NYSE: LLY) today announced new Phase 1 data showing that its folate receptor alpha (FRα) antibody-drug conjugate (ADC) (LY4170156) demonstrated an encouraging safety profile and anti-tumor activity across dose and FRα expression levels in women with heavily pre-treated platinum-resistant ovarian cancer, including patients previously treated with mirvetuximab soravtansine. A preliminary overall objective response rate (ORR) of 55% was observed at the potential recommended P

PR Newswire 14 days ago

LLY
Lilly announces details of presentations at American Diabetes Association's (ADA) 85th Scientific Sessions

Eli Lilly and Company (NYSE: LLY) today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at the American Diabetes Association's (ADA) 85th Scientific Sessions taking place June 20-23 in Chicago.

PR Newswire 17 days ago

LLY
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

Investor's Business Daily 18 days ago

LLY

NONOF

NVO

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Eli Lilly and Company (0Q1G.IL)

Lilly to offer all approved doses of Zepbound (tirzepatide) single-dose vials through LillyDirect Self Pay Pharmacy Solutions

Pharma manufacturing 'boom' faces high costs, potential delays

Tariffs Create Most Patriotic Earnings Season Yet as US Firms Pander to Trump

Abbott Laboratories Stock Sees RS Rating Rise To 82

Eli Lilly (NYSE:LLY) Collaborates With Juvena To Enhance Muscle Health Through AI Technology

Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel

Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to

Eli Lilly telehealth deals to prevent sale of compounded GLP-1s

Weight-Loss Drugs Pose Long-Term Threat To McDonald's: Analyst

Obesity Newcomer Metsera Enters The Ring With A Punch — And A Big Stock Jump

Challenges pharma companies face in push into US manufacturing

The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.

Salesforce initiated, Dollar Tree upgraded: Wall Street’s top analyst calls

Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Booster Shot

These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Broadcom Results Ahead

Eli Lilly (NYSE:LLY) Advances Ovarian Cancer Treatment And Transfers Cialis Rights In Latin America

Lilly to participate in Goldman Sachs 46th Annual Global Health Care Conference

Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting

Lilly announces details of presentations at American Diabetes Association's (ADA) 85th Scientific Sessions

Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly